BioVector? NCM460D Human Normal Colon Mucosal Epithelial Cell Line / NCM460D 人正常結(jié)腸黏膜上皮細(xì)胞株

一 產(chǎn)品基本信息與細(xì)胞生物學(xué)背景

• 細(xì)胞名稱：NCM460D（亦常寫作 NCM460-D 或衍生自 NCM460 親本系）。

• 物種來源：人類（Homo sapiens）。

• 組織源起與生物學(xué)背景（腸道藥理學(xué)與消化道生理學(xué)的黃金“正常”對照）：

  NCM460D 是一株源自人類正常結(jié)腸黏膜上皮組織的體外自發(fā)永生化（Spontaneously immortalized）細(xì)胞系。該系的原始親本株（NCM460）最初由科研人員（Moyer 等人）自一名 68 歲的西班牙裔男性（臨床上因胃癌接受手術(shù)，但結(jié)腸切緣病理學(xué)證實(shí)完全屬于組織學(xué)正常結(jié)腸黏膜）體內(nèi)分離并原代培養(yǎng)獲得。

  在消化道體外模型開發(fā)中，結(jié)腸癌細(xì)胞系（如 Caco-2, HT29, HCT116）極為普遍，但這些細(xì)胞由于惡性轉(zhuǎn)化，其代謝和信號通路已發(fā)生嚴(yán)重變異。為了建立一個(gè)能真實(shí)表征人類體內(nèi)正常大腸上皮生理機(jī)能的平臺，科研人員在不引入任何外源致癌病毒基因（如 SV40 T 突變）或外源轉(zhuǎn)染遺傳信息的天然狀態(tài)下，通過體外長期培養(yǎng)和連續(xù)傳代，成功篩選出了這株獲得無限分裂增殖能力的自發(fā)永生化克隆型上皮細(xì)胞株 NCM460D。它保留了極高質(zhì)量的正常結(jié)腸上皮細(xì)胞功能屬性。

• 核心表型與細(xì)胞生物學(xué)特征（質(zhì)控指標(biāo)）：

  • 生長特性與雙相培養(yǎng)表型（核心操作細(xì)節(jié)）：

    NCM460D 在塑料培養(yǎng)瓶中主要表現(xiàn)為混合型生長特征（Mixed monolayer/suspension culture）。雖然在常規(guī)匯合度下以嚴(yán)格貼壁的單層上皮樣生長（Monolayer cells predominate）為主，但當(dāng)細(xì)胞密度上升或處于特定周期時(shí)，培養(yǎng)基中會天然出現(xiàn)部分成簇或單散的懸浮/半懸浮細(xì)胞（Floating population / "floaters"）。核心質(zhì)控警告：這些懸浮成分絕非死細(xì)胞，而是該株系特有的分化或活躍增殖子代亞群。在日常換液與傳代時(shí)，必須通過離心將貼壁段與懸浮段合并保留，嚴(yán)禁直接抽干棄去懸浮細(xì)胞！

  • 表面分子與分泌圖譜：經(jīng)免疫組織化學(xué)與分子靶向鑒定，該細(xì)胞強(qiáng)表達(dá)結(jié)腸上皮特異性關(guān)聯(lián)抗原：細(xì)胞角蛋白（Cytokeratins）和絨毛蛋白（Villin），同時(shí)人類分泌成分（Secretory component）呈強(qiáng)陽性；而針對神經(jīng)元、內(nèi)皮細(xì)胞或成纖維細(xì)胞的特異性抗原檢測則表現(xiàn)為絕對陰性。此外，群體中部分特異性亞群能夠自發(fā)進(jìn)行黏液（Mucin）的合成與分泌。

  • 致瘤性狀態(tài)（Tumorigenicity）：在其早、中期代數(shù)質(zhì)檢中，該細(xì)胞表現(xiàn)出正常的生長限制，在軟瓊脂（Soft agar）中無法克隆化生長，且對無毛裸鼠（Nude mice）或胸腺缺陷小鼠進(jìn)行皮下接種后不具備致瘤性（Non-tumorigenic）。然而，由于長期體外傳代（In vitro selection壓力），晚期代數(shù)可能會出現(xiàn)核型異常并獲得部分轉(zhuǎn)化特征，實(shí)驗(yàn)中需高度關(guān)注代數(shù)窗口。

• 生物安全級別：1級（BSL-1）。

二 核心科研價(jià)值與腸道屏障/代謝毒理醫(yī)學(xué)應(yīng)用

N2a/APP695swe 等疾病株需要耐藥靶點(diǎn)，而 NCM460D 則作為整條消化道“健康與穩(wěn)態(tài)”的黃金基石：

1. 結(jié)腸癌（Colorectal Cancer）研究中的非腫瘤惡性轉(zhuǎn)化“陰性對照”：

   在評估新型抗癌靶向化療藥、小分子抑制劑或天然抗腫瘤中藥時(shí)，NCM460D 常與 Caco-2 或 HT29 等結(jié)腸癌靶盤并列應(yīng)用。通過對比兩者的 $IC_{50}$、凋亡誘導(dǎo)率，用以確證化合物是否具備“高效低毒”的腫瘤特異性殺傷窗口，確保其對人體正常腸黏膜不具備顯著的細(xì)胞毒性。

2. 腸黏膜物理屏障、緊密連接與離子轉(zhuǎn)運(yùn)（Ion Transport）研究：

   在多孔通透性膜（Transwell）上培養(yǎng)時(shí)，NCM460D 單層細(xì)胞能發(fā)育形成具有一定跨上皮電阻（TEER, 通?？蛇_(dá) $120 - 250\ \Omega\cdot\text{cm}^2$）的極化單層。它天然具備囊性纖維化跨膜電導(dǎo)調(diào)節(jié)器（CFTR）、鈉-鉀-2氯共轉(zhuǎn)運(yùn)體（NKCC1）等離子通道，是研究結(jié)腸隱窩（Crypt）中 cAMP、cGMP 和 $Ca^{2+}$ 依賴性氯離子（$Cl^-$）轉(zhuǎn)運(yùn)、腹瀉發(fā)生機(jī)制的核心模型。

3. 膳食營養(yǎng)素、食品添加劑（如卡拉膠等）以及環(huán)境毒素的腸道毒理學(xué)評價(jià)：

   廣泛應(yīng)用于食品衛(wèi)生和藥物代謝（ADME）研究。模擬人類攝入外源物質(zhì)（抗生素、食品防腐劑、微塑料等）后，正常腸上皮細(xì)胞發(fā)生細(xì)胞信號轉(zhuǎn)導(dǎo)異常、促炎細(xì)胞因子（Cytokine production）暴發(fā)、氧化應(yīng)激或胞間緊密連接蛋白（ZO-1, Occludin）斷裂的病理演變流線。

三 實(shí)驗(yàn)室細(xì)胞復(fù)蘇、雙相動態(tài)維持、常規(guī)傳代與質(zhì)控標(biāo)準(zhǔn)步驟

1. 專用培養(yǎng)基、血清比例與環(huán)境物理常數(shù)

• 基礎(chǔ)培養(yǎng)基（重點(diǎn)選型）：

  • 原廠推薦：INCELL 公司專有的高度富集 M3:10? 培養(yǎng)基（M310A，已含補(bǔ)充劑、10% 胎牛血清及雙抗），該培養(yǎng)基對長期維持 NCM460D 的高擬真上皮表型最為穩(wěn)定。

  • 通用常規(guī)替代：高質(zhì)量高糖 RPMI-1640 或者是 MEM 基礎(chǔ)培養(yǎng)基。

• 完全培養(yǎng)基典型配方（常規(guī)渠道）：

  • 高糖 RPMI-1640 或 MEM 基礎(chǔ)培養(yǎng)基

  • 加 10% - 15% 優(yōu)質(zhì)胎牛血清（FBS）（注：由于該細(xì)胞生長較為嚴(yán)苛且?guī)в袘腋喨?，部分?shí)驗(yàn)室推薦首代復(fù)蘇或狀態(tài)不佳時(shí)將血清濃度上調(diào)至 15% 以促進(jìn)貼壁擴(kuò)增）。

  • 加 1% 青霉素-鏈霉素雙抗。

• 物理生長環(huán)境：37 攝氏度，恒溫、飽和高濕度，含 5% 二氧化碳（$CO_2$） 的無菌孵箱。

2. 雙相混合細(xì)胞的復(fù)蘇與全量留存步序

1. 提前在生物安全柜中準(zhǔn)備好干凈的 T25 或 T75 培養(yǎng)瓶，注入 5 - 10 mL 預(yù)熱至 37 ℃ 的完全培養(yǎng)基。

2. 從液氮罐中取出 NCM460D 凍存管，迅速全量浸入 37 ℃ 恒溫水浴箱中快速用力晃動，確保在 1 分鐘左右令管內(nèi)冰塊完全融化。

3. 用 75% 酒精噴灑消毒外壁，移入安全柜。

4. 將凍存管內(nèi)的細(xì)胞懸液緩慢滴加至盛有 4 - 5 mL 預(yù)熱完全培養(yǎng)基的 15 mL 離心管中，輕柔顛倒混勻。

5. 以 1000 rpm（約 200 g）進(jìn)行溫和離心 5 分鐘。

6. 小心抽干含有 DMSO 的毒性上清液，注意切勿抽到管底。

7. 加入 1.5 mL 新鮮完全培養(yǎng)基，用移液槍輕柔吹打 3 - 5 次重懸細(xì)胞沉淀。

8. 將懸液接種至準(zhǔn)備好的培養(yǎng)瓶中，十字搖勻，置于 37 ℃ 孵箱中培養(yǎng)。

9. 復(fù)蘇 24 小時(shí)后的核心操作（關(guān)鍵換液工藝）：

   由于 NCM460D 具有貼壁/懸浮雙相特性，復(fù)蘇 24 小時(shí)后，培養(yǎng)基中會有未貼壁的死細(xì)胞碎屑，也會混有正常的懸浮活細(xì)胞亞群。此時(shí)建議采取“半換液或離心換液法”：將培養(yǎng)基吸出至 15 mL 離心管中，1000 rpm 離心 5 分鐘，棄上清（去除碎屑）；用 5 mL 全新完全培養(yǎng)基重懸管底的懸浮細(xì)胞泥，然后再全量倒回原培養(yǎng)瓶中（原瓶壁上已貼有一層單層上皮細(xì)胞）。通過該操作，完美保留雙相種子。

3. 日?；旌蟼鞔僮鳎笇W(xué)解離與混合收集法）

• 傳代時(shí)機(jī)：當(dāng)貼壁的單層上皮細(xì)胞達(dá)到 80% - 90% 匯合度 時(shí)必須傳代。該細(xì)胞群體倍增時(shí)間相對較慢，約為 32 - 38 小時(shí)。通常每 3 - 5 天傳代一次。切忌讓貼壁層過度長滿（$\gt 95\%$），否則懸浮段的細(xì)胞會過度聚集成極難解離的致密大團(tuán)塊，引發(fā)內(nèi)部接觸抑制紊亂和上皮表型老退。

• 操作流程（混合傳代法）：

  1. 收集懸浮段：首先用移液管直接吸出培養(yǎng)瓶中的全部上清液（內(nèi)含懸浮的 "floaters" 細(xì)胞群），轉(zhuǎn)移至無菌 15 mL 離心管中。

  2. 清洗貼壁層：向瓶內(nèi)殘留的貼壁細(xì)胞層表面加入無鈣鎂離子的無菌 PBS 緩沖液輕輕漂洗 1 次，洗凈殘余血清，隨后吸除 PBS。

  3. 酶學(xué)解離：向瓶內(nèi)加入適量 0.25% Trypsin-EDTA 消化液（T25 瓶加入 1 mL），使其均勻覆蓋細(xì)胞層，隨后置于 37 ℃ 孵箱中消化。

  4. 鏡下動態(tài)觀察：通常消化 1 - 3 分鐘。在倒置顯微鏡下動態(tài)觀察，一旦發(fā)現(xiàn)多角形貼壁細(xì)胞回縮變圓、胞間縫隙增大、且輕敲培養(yǎng)瓶時(shí)細(xì)胞松動向下滑落，立刻向瓶內(nèi)注入 2 倍體積的含血清完全培養(yǎng)基終止消化。

  5. 用移液槍輕柔吹打瓶壁 3 - 4 次使貼壁細(xì)胞徹底脫落，調(diào)理成均勻的單細(xì)胞懸液。

  6. 合流離心：將瓶內(nèi)這部分消化下來的細(xì)胞懸液，全部合并傾倒至步驟1中盛有懸浮細(xì)胞上清的 15 mL 離心管中（使貼壁段與懸浮段匯合）。

  7. 以 1100 rpm 離心 4 - 5 分鐘，徹底棄去含有胰酶的上清液。

  8. 加入新鮮完全培養(yǎng)基，用移液槍反復(fù)輕柔吹打，直至將貼壁和懸浮成分完全打散成單細(xì)胞狀態(tài)。

  9. 按照 1:2 至 1:3 的常規(guī)保守傳代比例（首次傳代推薦 1:3 初始鋪板密度，確保每 75 $cm^2$ 面積內(nèi)至少含有 $2 - 8 \times 10^5$ 個(gè)活細(xì)胞），接種至新培養(yǎng)瓶中，補(bǔ)足完全培養(yǎng)基，放回孵箱。

4. 屏障與毒理實(shí)驗(yàn)?zāi)Ｐ头€(wěn)定性控制

1. 代數(shù)限制與表型漂移（Passage Control）：雖然 NCM460D 屬于自發(fā)永生化細(xì)胞系，但長期連續(xù)體外傳代（通常超過 30 - 40 代以后）會導(dǎo)致其原本的正常非癌變表型發(fā)生傾斜，表現(xiàn)為跨上皮電阻值（TEER）無法達(dá)標(biāo)、或逐漸獲得軟瓊脂克隆生長能力。因此，用于屏障評價(jià)、毒理測試和離子轉(zhuǎn)運(yùn)實(shí)驗(yàn)的細(xì)胞，代數(shù)必須嚴(yán)格控制在復(fù)蘇后的 20 代以內(nèi)，嚴(yán)禁使用出現(xiàn)嚴(yán)重核型漂移的晚期老化細(xì)胞。

2. 狀態(tài)監(jiān)測質(zhì)控：傳代時(shí)如果由于漏換液導(dǎo)致懸浮大細(xì)胞團(tuán)塊無法被胰酶打散，后期會在瓶底形成局部“火山堆樣”的異態(tài)重疊生長。一旦在鏡下頻繁觀察到極度致密、無法吹散的結(jié)節(jié)狀細(xì)胞團(tuán)，說明群落動力學(xué)已變異，建議終止該批次。

5. 細(xì)胞長期保存標(biāo)準(zhǔn)

• 凍存液配方：50% 基礎(chǔ) RPMI-1640/MEM 培養(yǎng)基 + 40% 優(yōu)質(zhì)胎牛血清（FBS） + 10% 最高分析級二甲基亞砜（DMSO）；或者使用原廠推薦的無血清高保護(hù)級細(xì)胞凍存液。

• 梯度冷凍規(guī)范：

  1. 按照傳代法，合并收集處于對數(shù)生長最旺盛期（貼壁層匯合度約 80%）、健康度標(biāo)桿的 NCM460D 貼壁與懸浮細(xì)胞，離心吸除上清。

  2. 用配制好的冷凍液懸浮并計(jì)數(shù)，調(diào)整細(xì)胞終密度至 每毫升 1,500,000 - 3,000,000 個(gè)活細(xì)胞 之間。

  3. 分裝入無菌專用凍存管，擰緊管蓋，立刻移入標(biāo)準(zhǔn)程序降溫盒（Mr. Frosty）。

  4. 將降溫盒投入 -80 ℃ 超低溫冰箱中慢速梯度降溫過夜（確保達(dá)到 $-1\text{ }^\circ\text{C/min}$ 的標(biāo)稱降溫速率）。

  5. 24 小時(shí)內(nèi)，迅速將凍存管轉(zhuǎn)移并鎖死在液氮罐（-196 ℃）的液相層或氣相層中長期存放。嚴(yán)禁在 -80 ℃ 冰箱中無限期擱置，防止微弱的溫度震蕩破壞該自發(fā)永生化細(xì)胞特有的雙相膜結(jié)構(gòu)完整性。

BioVector? NCM460D Human Normal Colon Mucosal Epithelial Cell Line / NCM460D 人正常結(jié)腸黏膜上皮細(xì)胞株 (English Version)

I Product General Information and Cell Biological Background

• Cell Line Name: NCM460D (Alternative nomenclature: NCM460-D or derived sub-clones of the parent NCM460 line).

• Organism Source: Human (Homo sapiens).

• Tissue Extract and Background (The Gold-Standard "Normal" Control for Intestinal Pharmacology and GI Physiology):

  NCM460D represents a spontaneously immortalized epithelial cell line derived from histologically normal human colon mucosal tissue. The original parental line (NCM460) was isolated by Moyer and colleagues from the transverse colon mucosa of a 68-year-old Hispanic male patient undergoing surgery for gastric carcinoma. Importantly, pathology confirmed the donor's colonic margins were entirely normal, clear of disease, and histologically sound.

  While malignant colorectal cancer lines (e.g., Caco-2, HT29, HCT116) are ubiquitous in gastrointestinal research, their severe oncogenic mutations skew metabolic pathways and signaling cascades. To overcome this limitation, NCM460D was established through long-term in vitro cultivation and continuous passaging without the introduction of any heterologous viral oncogenes (such as SV40 Large T antigen) or exogenous transgenes. The resulting line possesses an indefinite replicative lifespan while preserving the non-malignant physiological and functional properties of normal human large intestinal epithelium.

• Core Morphological Phenotype and Characterization Parameters:

  • Biphasic Proliferation Profiling (Critical Operational Detail):

    NCM460D exhibits a mixed monolayer/suspension growth phenotype when cultivated on standard tissue culture plasticware. While the culture is dominated by a strictly adherent epithelial-like monolayer at standard densities, it naturally sheds a distinct population of viable single cells or clusters that grow in suspension/semi-suspension ("floaters") as density escalates or cells progress through specific cell cycle checkpoints.

    CRITICAL QUALITY CONTROL WARNING: These suspended elements are NOT dead cell fragments; they constitute a highly viable, proliferating sub-population crucial to the line's multi-lineage dynamic state. During routine media replacement and subculturing, this floating segment MUST be harvested, spun down, and combined with the adherent layer. Never aspirate and discard the floating cells.

  • Surface Antigen and Secretory Footprint: Immunocytochemical and molecular analysis confirms that NCM460D strongly expresses epithelial-specific lineage markers, including cytokeratins and villin, alongside the human secretory component. Conversely, the line tests completely negative for markers specific to neuronal, endothelial, or fibroblastic lineages. Furthermore, specialized sub-populations within the line retain the capacity for spontaneous mucin synthesis and secretion.

  • Tumorigenic Assessment: At early and mid-passage stages, NCM460D exhibits strict growth constraints. It fails to form colonies in soft agar assays and is non-tumorigenic when subcutaneously inoculated into athymic nude mice or thymus-deficient animal matrices. However, because extended in vitro passaging introduces long-term selection pressure, late-passage cultures may undergo karyotypic drifting and pick up transformed traits. Strict tracking of passage numbers is mandatory.

• Biosafety Threshold: Rated at Biosafety Level 1 (BSL-1).

II Strategic Research Value and Intestinal Barrier/Toxicological Applications

While disease-specific cell lines are implemented to isolate resistance markers, NCM460D functions as a crucial "healthy baseline" control for gastrointestinal physiology:

1. The Non-Malignant "Negative Control" in Colorectal Cancer (CRC) Screenings:

   When evaluating novel targeted chemotherapeutics, small-molecule inhibitors, or natural anti-tumor botanical compounds, investigators deploy NCM460D in parallel with colorectal cancer lines (e.g., Caco-2, HT29). By comparing comparative $IC_{50}$ values and apoptosis induction rates, researchers establish whether a compound exhibits a true, tumor-specific therapeutic window without causing toxic off-target damage to normal, healthy intestinal mucosa.

2. Intestinal Mucosal Physical Barrier, Tight Junctions, and Ion Transport:

   When cultured on porous permeable supports (Transwell inserts), NCM460D monolayers develop polarized configurations that generate a measurable transepithelial electrical resistance (TEER, standardly scaling to $120 - 250\ \Omega\cdot\text{cm}^2$). It constitutively expresses vital ion channels, including the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and the Sodium-Potassium-Chloride Cotransporter (NKCC1), rendering it an optimal model for investigating cAMP-, cGMP-, and $Ca^{2+}$-dependent chloride ($Cl^-$) transport dynamics across colonic crypt architectures during diarrheal pathogen exposure.

3. Intestinal Toxicological Evaluation of Nutrients, Food Additives, and Xenobiotics:

   NCM460D is widely integrated into food safety testing and ADME (Absorption, Distribution, Metabolism, and Excretion) studies. It simulates the human gut's physiological response to ingested substances—such as therapeutic antibiotics, food emulsifiers (e.g., carrageenan), microplastics, or environmental toxins—mapping intracellular signaling disruptions, pro-inflammatory cytokine cascades, oxidative stress profiling, and the degradation of intercellular tight junction proteins (ZO-1, Occludin).

III Laboratory Thawing, Biphasic Cultivation, Passaging, and Quality Controls

1. Basal Media Optimization and Physical Environmental Settings

• Basal Medium Base (Strict Selection Requirements):

  • Primary Manufacturer Recommendation: INCELL's proprietary, enriched M3:10? medium (M310A, pre-formulated with essential supplements, 10% Fetal Bovine Serum, and antibiotics). This matrix yields the highest long-term stability for preserving authentic human colonic epithelial phenotypes.

  • Standard Laboratory Alternative: Premium High-Glucose RPMI-1640 or standard MEM basal formulation.

• Complete Growth Matrix Formulation (Standard Alternate Configuration):

  • High-Glucose RPMI-1640 or MEM basal template

  • Supplemented with 10% – 15% premium Fetal Bovine Serum (FBS). Note: Because this line can be fastidious and relies on a sensitive balance between adherent and floating segments, elevating the serum concentration to 15% during initial post-thaw recovery or phases of low viability is highly recommended to stimulate attachment and growth.

  • Fortified with 1% standard Penicillin-Streptomycin dual antibiotic cocktail.

• Physical Processing Constants: Calibrate the incubator strictly to 37 °C, packed with 5% Carbon Dioxide ($CO_2$) under continuous humified saturation conditions.

2. Biphasic Culture Thawing and Complete Cell Recovery Protocol

1. Pre-warm a sterile T25 or T75 culture flask filled with 5 – 10 mL of complete growth medium to 37 °C inside the biosafety workstation.

2. Retrieve the NCM460D cryovial from liquid nitrogen storage and submerge it instantly within a 37 °C water bath. Agitate continuously to melt the internal matrix within 60–90 seconds.

3. Mist the exterior shell with 75% ethanol before transfer into the sterile workstation.

4. Draw up the liquid and transfer it slowly into a 15 mL conical tube containing 4 – 5 mL of pre-warmed complete growth medium to dilute the toxic DMSO footprint.

5. Centrifuge the suspension at a gentle velocity of 1000 rpm (~200 g) for 5 minutes.

6. Aspirate the chemical-laden supernatant completely, taking care not to disturb the underlying pellet.

7. Administer 1.5 mL of fresh complete growth medium onto the pellet, resuspending via gentle pipetting (3 – 5 strokes max).

8. Dispense the cells into the prepared culture flask, mix gently in a cross pattern, and place into the 37 °C incubator.

9. Critical Handling Step at 24 Hours Post-Thaw (Biphasic Retention Wash):

   Because NCM460D exhibits a dual adherent/suspension nature, the culture fluid at 24 hours will contain a mixture of dead cell fragments from cryo-stress and healthy, viable floating epithelial subsets. To protect this delicate population, implement a "centrifugal media replacement method": Aspirate the entire culture supernatant into a sterile 15 mL tube and centrifuge it at 1000 rpm for 5 minutes. Discard the supernatant (removing debris), resuspend the remaining viable floating cell pellet in 5 mL of fresh complete growth medium, and return this suspension back into the original flask (where the initial adherent monolayer is already fixed to the plastic surface). This process fully re-establishes the crucial biphasic seed stock.

3. Routine Biphasic Subculturing and Passaging Routines

• Confluency Assessment Control: Initialize passaging workflows when the adherent epithelial monolayer achieves 80% – 90% confluency. The population doubling time of NCM460D ranges from 32 to 38 hours under optimal conditions; expect a standard passaging schedule every 3 to 5 days. Never allow the adherent monolayer to become over-confluent ($\gt 95\%$), as the floating segment will form dense, highly compacted aggregates that resist enzymatic dissociation. This induces contact-inhibition stress and triggers phenotypic degradation.

• Passaging Execution Steps (Unified Mixed-Phase Method):

  1. Harvest the Floating Segment: Directly aspirate the entire volume of spent growth fluid (containing the vital floating sub-population) and transfer it into a sterile 15 mL conical tube.

  2. Wash the Adherent Bed: Rinse the remaining adherent monolayer gently with sterile, calcium/magnesium-free PBS to remove residual serum proteins, then aspirate and discard the PBS wash.

  3. Enzymatic Dissociation: Apply an appropriate layer of 0.25% Trypsin-EDTA solution (typically 1 mL for a T25 format) directly onto the monolayer and incubate at 37 °C.

  4. Microscopic Tracking: Maintain continuous visual monitoring under the microscope. Trypsinization typically completes within 1 – 3 minutes at 37 °C. The moment the polygonal adherent cells contract, cell boundaries expand, and cells slide off the surface upon gentle tapping, immediately add 2 volumes of serum-fortified complete growth medium to halt enzymatic cleavage.

  5. Gently pipette the suspension 3 to 4 times against the flask wall to ensure complete detachment and break up early clusters.

  6. Phase Convergence: Transfer this trypsinized cell suspension directly into the same 15 mL tube containing the original floating cell supernatant harvested in Step 1 (merging both adherent and suspension fractions).

  7. Centrifuge the unified suspension at 1100 rpm for 4 – 5 minutes, then completely aspirate and discard the trypsin-laden fluid.

  8. Resuspend the consolidated pellet in fresh complete growth medium, pipetting gently but thoroughly until both fractions are dissociated into a homogenous single-cell suspension.

  9. Distribute the cells into new flasks utilizing standard conservative split ratios of 1:2 to 1:3 (ensuring a minimum seeding density of $2 - 8 \times 10^5$ viable cells per 75 $cm^2$ surface area). Top off with complete growth medium and return to the incubator.

4. Barrier and Toxicological Assay Quality Controls

1. Passage Threshold Restrictions and Phenotypic Drift: Although NCM460D is a spontaneously immortalized line, extended, continuous cultivation (typically beyond 30 to 40 passages post-receipt) can shift its non-malignant phenotype. This drift presents as a progressive loss of tight junction formation (indicated by a drop in baseline TEER values) or the spontaneous acquisition of anchorage-independent growth in soft agar. Consequently, cells designated for barrier integrity evaluation, toxicological mapping, or ion transport assays must be strictly restricted to fewer than 20 passages post-thaw. Never use late-passage cultures that exhibit karyotypic drift.

2. Morphological Aberration Audit: If regular media replacements are missed, the floating aggregates can form dense, nodular clusters that resist trypsinization. This causes irregular, multi-layered "volcanic-like" stacking on the flask floor. If these tightly bound, indissociable cell nodules appear frequently under the microscope, the culture dynamics have drifted, and the batch must be discarded.

5. Long-Term Cryopreservation Parameters

• Cryoprotectant Preservation Formula: 50% basal RPMI-1640/MEM growth medium blended with 40% premium Fetal Bovine Serum (FBS) and 10% analytical-grade Dimethyl Sulfoxide (DMSO), or a certified serum-free, high-protection commercial freezing matrix.

• Controlled Gradient Freezing Protocol:

  1. Harvest highly viable, mid-log phase cultures (adherent monolayer at approximately 80% confluency), pooling both the adherent and floating segments according to the unified passaging protocol. Centrifuge and isolate the pellet.

  2. Resuspend the cells in the pre-chilled cryoprotectant matrix, adjusting the target density to between 1,500,000 and 3,000,000 viable cells per milliliter.

  3. Transfer the solution into sterile cryovials, tightening the caps securely to maintain an airtight seal.

  4. Place the vials immediately into a standard controlled-rate cooling container (e.g., Mr. Frosty).

  5. Deposit the cooling container inside a -80 °C ultra-low freezer overnight to execute a steady cooling rate of -1 °C/minute.

  6. Within 24 hours, quickly transfer the vials into liquid nitrogen storage tanks (-196 °C) for long-term preservation. Do not store vials indefinitely inside a -80 °C freezer, as minor temperature variations can compromise membrane integrity and degrade the specialized biphasic structure of this spontaneously immortalized epithelial line.

BioVector NTCC質(zhì)粒載體菌株細(xì)胞蛋白抗體基因保藏中心

電話:400-800-2947

工作QQ/微信同號:1843439339

網(wǎng)址http://www.nedfriskphoto.com